AGP Picks
View all

My European News: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on My European News.

Press releases published on August 5, 2026

Una nuova ricerca globale di Velo rivela l’effetto domino dell’espressione di sé
„Velo“ atliktas naujas pasaulinis tyrimas atskleidė saviraiškos „grandininę reakciją“
Nowe globalne badanie Velo ujawnia „efekt domina” wynikający z wyrażania siebie
Ny global forskning från Velo avslöjar hur effekterna av personliga uttryck sprider sig som ”ringar på vatten”
Velo'nun Yaptırdığı Yeni Küresel Araştırma Kendini İfade Etmenin "Dalga Etkisini" Ortaya Çıkardı
MoonPay Brings Gasless Transactions to TRON, Simplifying Stablecoin Payments
CGPH Banque d’affaires Obtains EUR 104 Million in Financing Approvals in the First Half of 2026
Kilbourne Graphite Advances Towards Commercialization with Global Refractory Manufacturer
Transaction in Own Shares
Director/PDMR Shareholding
Trident Resources Provides La Ronge Gold Belt Exploration Update and Appoints Indigenous Engagement Consultant
Zeotap launches end-to-end Composable CDP Native App on Snowflake Marketplace
Multiverse Computing and Qualcomm Collaborate to Bring Efficient AI Models to Data Centers
Mironid raises $46 million in Series B financing to advance clinical development of its treatment for rare kidney disease
Wolters Kluwer 2026 Half-Year Report
Not Every Fragrance Begins in a Boutique: Oud of London Makes Its Debut Onboard Emirates
Basilea erhält zusätzliche USD 5.4 Mio. von BARDA zur Entwicklung des neuartigen Antibiotikums Ceftibuten-Ledaborbactam
Basilea receives additional USD 5.4 million from BARDA to continue development of novel antibiotic ceftibuten-ledaborbactam

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

My European News

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.